Pinduoduo (PDD US) : Well Positioned For Upcoming Recovery
Pinduoduo (PDD US) : Well Positioned For Upcoming Recovery
Pinduoduo (PDD US) : Well Positioned For Upcoming Recovery
Stock Data
Eye-catching 1Q22. 1Q22 rev +7% YoY, 15% above consensus (on resilient Mkt Cap (US$ mn) 46,732
GMV and rising take rate). We are impressed by its strong OMS growth, +29% Avg 3 mths t/o (US$ mn) 774.76
YoY in 1Q22 (vs. 19% in 4Q21). AAC +7% YoY, up to 882mn (13mn net adds). 52w High/Low (US$) 143.11/23.21
Non-GAAP net profit came in at RMB4.2bn (with adj. NPM at 18%), largely Total Issued Shares (mn) 1,264
Source: Bloomberg
above consensus at RMB2.6bn, mainly on higher GPM and disciplined S&M
control (S&M/Rev ratio (ex-1P biz) at -47% in 1Q22, vs. -59% in 1Q21). We Shareholding Structure
view this result as positive, given its resilient topline growth with upbeat margin, Nanpeng Shen 15.21%
despite challenging environment. Baillie Gifford 2.30%
FMR LLC 1.98%
Well positioned for upcoming recovery after lockdowns relaxation. We Source: Bloomberg
think that 2Q22E would be the most muted season for epidemic resurgence,
for ecommerce players. However, we think that PDD would be more resilient Share Performance
than peers, for its value-for-money products and relatively higher GMV Absolute Relative
1-mth 6.4% 21.3%
exposure in lower-tier cities. We expect May’s volume to improve from Apr, 3-mth -27.6% -13.4%
and PDD to well positioned for upcoming recovery with lockdowns relaxation. 6-mth -54.6% -36.1%
We forecast its GMV +5% YoY in 2Q22E, and then rebound to double-digit Source: Bloomberg
growth in 2H22E. DDMC performed well, and even surpassed some metrics
of competitor in 1Q22, according to third-party channel. We expect DDMC’s 12-mth Price Performance
UE improvement to continue. We turn more positive on PDD’s margin outlook, (US$) PDD US CCMP (rebased)
180
backed by more disciplined S&M offsetting by RMB10bn Agriculture Initiative 160
<百亿农研>. 140
120
Maintain BUY. We raised its earnings by 5%-9% in FY22-24E, with adj. NPM 100
80
by 1ppt, to reflect disciplined expenses. Maintain BUY with higher DCF-based 60
TP at US$70 (32x FY23E P/E). 40
20
0
May-21 Aug-21 Nov-21 Feb-22
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
MORE REPORTS FROM BLOOMBERG: RESP CMBR <GO> AND http://www.cmbi.com.hk
30 May 2022
Margin (%)
Gross margin 72.0% 78.2% 77.1% 56.6% 51.5% 65.7% 69.5% 76.1% 69.9% 66.5%
Operating margin -67.2% -13.4% -9.1% -7.7% -18.7% 8.7% 9.9% 25.4% 9.1% 5.5%
Adj. net margin -48.5% -0.6% 3.3% -0.7% -8.5% 17.9% 14.6% 31.0% 17.7% 12.8%
Growth (%)
Revenue (YoY) 43.9% 67.3% 89.1% 146.0% 238.9% 89.0% 51.3% 2.6% 7.3% -22.2%
Revenue (QoQ) -39.4% 86.4% 16.5% 86.8% -16.5% 4.0% -6.7% 26.6% -12.6% -4.0%
Operating profit NA NA NA NA NA NA NA NA NA NA
Adj. net profit NA NA NA NA NA NA NA NA NA NA
Source: Company data, Bloomberg
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
30 May 2022
Financial Summary
Income statement Cash flow summary
YE 31 Dec (RMB mn) FY20A FY21A FY22E FY23E FY24E YE 31 Dec (RMB mn) FY20A FY21A FY22E FY23E FY24E
Revenue 59,492 93,950 104,714 122,250 138,281 Net income (7,180) 7,769 11,648 15,689 21,183
Online marketing 47,954 72,563 87,788 102,798 116,808 D&A 652 885 1,152 1,238 1,377
Transaction 5,787 14,140 16,649 19,132 21,473 Change in WC (370) 30,933 9,774 15,510 14,225
Merchant Sales 5,751 7,248 277 319 - Others 3,613 4,698 5,236 5,807 6,240
COGS (19,279) (31,718) (32,307) (37,107) (42,091) Operating CF (3,285) 44,285 27,809 38,244 43,024
Gross profit 40,213 62,232 72,407 85,142 96,190
Capex (116) (196) (218) (255) (288)
S&M (41,195) (44,802) (44,182) (49,636) (53,278) Associates - - - - -
Admin.Exp. (1,507) (1,541) (2,571) (2,901) (3,189) Others (32,603) (4,228) (4,189) (4,279) (4,425)
R&D (6,892) (8,993) (14,378) (17,902) (20,828) Investing CF (32,719) (4,424) (4,407) (4,533) (4,713)
Others - - - - -
Operating profit (9,380) 6,897 11,277 14,703 18,896 Equity raised 51,799 - - - -
Change of Debts - - - - -
Financial Cost 1,698 1,831 3,351 4,779 7,126 Others - - - - -
Associates 419 728 - - - Financing CF 51,799 - - - -
Pre-tax Income (7,263) 9,455 14,627 19,483 26,022
Net change in cash 15,795 39,861 23,403 33,710 38,311
Income Tax - (1,934) (2,979) (3,793) (4,839) Cash (beg of yr) 18,620 34,415 74,277 97,680 131,390
Convertible - - - - - FX - - - - -
preferred shares
Net profit (7,180) 7,769 11,648 15,689 21,183 Cash (end of yr) 34,415 74,276 97,680 131,390 169,701
Adj. net profit (2,965) 13,830 16,884 21,496 27,423
Balance sheet Key ratios
YE 31 Dec (RMB mn) FY20A FY21A FY22E FY23E FY24E YE 31 Dec FY20A FY21A FY22E FY23E FY24E
Non-current assets 9,385 11,540 15,177 19,443 23,941 Sales mix (%)
Fixed asset 203 233 300 398 581 Online marketing 80.6 77.2 83.8 84.1 84.5
Associates - - - - - Transaction services 9.7 15.1 15.9 15.7 15.5
Intangible assets 1,277 11,307 14,877 19,045 23,360 Merchant Sales 9.7 7.7 0.3 0.3 0.0
Others 7,275 - - - - Total 100.0 100.0 100.0 100.0 100.0
Current assets 149,524 149,760 174,391 210,154 250,635 Growth rate (%)
Cash 22,421 21,854 45,257 78,968 117,279 Revenue 97.4 57.9 11.5 16.7 13.1
Restricted cash 52,422 52,422 52,422 52,422 52,422 Gross profit 68.9 54.8 16.4 17.6 13.0
Account receivable 730 1,079 1,214 1,395 1,566 EBIT NA NA NA NA NA
Others 73,951 74,405 75,497 77,369 79,368 Net profit NA NA NA NA NA
Current liabilities 83,882 106,224 117,226 134,789 151,184 P&L ratios (%)
Amounts due to 3,386 3,168 3,226 3,705 4,203 Operating margin (15.8) 7.3 10.8 12.0 13.7
related parties
Customer advances 2,423 726 878 1,028 1,168 Pre-tax margin (12.2) 10.1 14.0 15.9 18.8
Payable to merchants 53,834 73,963 83,244 95,662 107,367 Adj. net margin (5.0) 14.7 16.1 17.6 19.8
Accrued expenses 11,193 12,342 13,230 15,261 16,972 Effective tax rate - (2.1) (20.4) (19.5) (18.6)
Merchant deposits 10,926 16,025 16,649 19,132 21,473
Returns (%)
Non-current 5,643 5,643 5,643 5,643 5,643 ROE (11.9) 17.6 20.2 20.5 21.1
liabilities
Convertible bonds 5,207 5,207 5,207 5,207 5,207 ROA (2.5) 8.6 9.6 10.3 10.9
Others 436 436 436 436 436
Per share
MI - - - - - Adj. EPS (RMB) (2.49) 9.56 11.45 14.29 17.87
Total Equity 69,384 49,433 66,699 89,165 117,750 DPS (RMB) 0.00 0.00 0.00 0.00 0.00
Shareholders' equity 60,176 72,642 89,526 111,022 138,445 BVPS (RMB) 13.18 11.55 12.51 16.07 20.50
Source: Company data, CMBIGM estimates
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
30 May 2022
CMBIGM Ratings
BUY : Stock with potential return of over 15% over next 12 months
HOLD : Stock with potential return of +15% to -10% over next 12 months
SELL : Stock with potential loss of over 10% over next 12 months
NOT RATED : Stock is not rated by CMBIGM
OUTPERFORM : Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM : Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM : Industry expected to underperform the relevant broad market benchmark over next 12 months
Important Disclosures
There are risks involved in transacting in any securities. The information contained in this report may not be suitable for the purposes of all investors. CMBIGM does
not provide individually tailored investment advice. This report has been prepared without regard to the individual investment objectives, financial position or special
requirements. Past performance has no indication of future performance, and actual events may differ materially from that which is contained in the report. The value
of, and returns from, any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the performance of underlying assets
or other variable market factors. CMBIGM recommends that investors should independently evaluate particular investments and strategies, and encourages investors
to consult with a professional financial advisor in order to make their own investment decisions.
This report or any information contained herein, have been prepared by the CMBIGM, solely for the purpose of supplying information to the clients of CMBIGM or its
affiliate(s) to whom it is distributed. This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in securities or
enter into any transaction. Neither CMBIGM nor any of its affiliates, shareholders, agents, consultants, directors, officers or employees shall be liable for any loss,
damage or expense whatsoever, whether direct or consequential, incurred in relying on the information contained in this report. Anyone making use of the information
contained in this report does so entirely at their own risk.
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable. CMBIGM
has exerted every effort in its capacity to ensure, but not to guarantee, their accuracy, completeness, timeliness or correctness. CMBIGM provides the information,
advices and forecasts on an "AS IS" basis. The information and contents are subject to change without notice. CMBIGM may issue other publications having information
and/ or conclusions different from this report. These publications reflect different assumption, point-of-view and analytical methods when compiling. CMBIGM may make
investment decisions or take proprietary positions that are inconsistent with the recommendations or views in this report.
CMBIGM may have a position, make markets or act as principal or engage in transactions in securities of companies referred to in this report for itself and/or on behalf
of its clients from time to time. Investors should assume that CMBIGM does or seeks to have investment banking or other business relationships with the companies in
this report. As a result, recipients should be aware that CMBIGM may have a conflict of interest that could affect the objectivity of this report and CMBIGM will not assume
any responsibility in respect thereof. This report is for the use of intended recipients only and this publication, may not be reproduced, reprinted, sold, redistributed or
published in whole or in part for any purpose without prior written consent of CMBIGM.
Additional information on recommended securities is available upon request.
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE